AGREEMENTAgreement • December 17th, 1996 • Chiron Corp • Pharmaceutical preparations • New York
OPTION AGREEMENT ----------------Option Agreement • November 12th, 1996 • Chiron Corp • Pharmaceutical preparations • California
REVOLVING CREDIT AGREEMENT REVOLVING CREDIT AGREEMENT (this "AGREEMENT") dated as of March 23, 1998 (the "EFFECTIVE DATE") between CHIRON CORPORATION, a Delaware corporation (the "BORROWER"), and SWISS BANK CORPORATION, STAMFORD BRANCH (the "BANK")....Revolving Credit Agreement • March 30th, 1998 • Chiron Corp • Pharmaceutical preparations • New York
REDACTED LICENSE AGREEMENTLicense Agreement • March 7th, 2001 • Chiron Corp • Pharmaceutical preparations • Washington
LETTERHEAD] LETTER AGREEMENTLetter Agreement • March 31st, 1997 • Chiron Corp • Pharmaceutical preparations • Delaware
I FORMATION OF THE COMPANYLimited Liability Company Agreement • March 28th, 1996 • Chiron Corp • In vitro & in vivo diagnostic substances • Delaware
or its subsidiaries pursuant to Section 1.04(iv)(3) of the Investment Agreement and consummation of such merger shall satisfy the Company's obligation to repay such amounts at the Closing pursuant to such Section 1.04 (iv)(3). (b) The Company shall...Agreement and Plan of Merger • November 12th, 1999 • Chiron Corp • Pharmaceutical preparations • Delaware
FORM T-1Chiron Corp • April 6th, 2000 • Pharmaceutical preparations
CONFIDENTIAL December 4, 1997 Mr. Peter Tattle Johnson & Johnson One Johnson & Johnson Plaza New Brunswick, NJ 08896 Dear Mr. Tattle: This letter agreement (this "AGREEMENT") sets forth the agreement of Chiron Corporation ("CHIRON"), on the one hand,...Letter Agreement • March 30th, 1998 • Chiron Corp • Pharmaceutical preparations
Exhibit 10.39 SECOND AMENDMENT TO LEASE THIS SECOND AMENDMENT TO LEASE ("Second Amendment") is made as of the 1st day of January, 1995, between HAROLD B. CHAPMAN, JR., an individual ("Chapman"), and CHIRON CORPORATION, a Delaware corporation...Lease • March 28th, 1996 • Chiron Corp • In vitro & in vivo diagnostic substances
RECITALSAgreement • August 12th, 1999 • Chiron Corp • Pharmaceutical preparations • California
REVOLVING CREDIT AGREEMENT REVOLVING CREDIT AGREEMENT (this "AGREEMENT") dated as of February 27, 1998, between CHIRON CORPORATION, a Delaware corporation (the "BORROWER") and BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION (the "BANK"). NOW,...Revolving Credit Agreement • March 30th, 1998 • Chiron Corp • Pharmaceutical preparations • California
NOTARIAL DEED ------------------------------------- PURCHASE AND ASSIGNMENT AGREEMENTLicense Agreement • November 12th, 1996 • Chiron Corp • Pharmaceutical preparations
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • August 21st, 2000 • Chiron Corp • Pharmaceutical preparations • Delaware
ISSUER TOIndenture • April 17th, 2000 • Chiron Corp • Pharmaceutical preparations • New York
AGREEMENT between GEN-PROBE INCORPORATED and CHIRON CORPORATION Dated as of June 11, 1998Agreement • March 7th, 2001 • Chiron Corp • Pharmaceutical preparations • California
During the 30-day period following Ciba's receipt of the Statement, Ciba and its independent auditors shall be permitted to review the working papers of Diagnostics' independent auditors relating to the Statement. The Statement shall become final and...Execution Copy • November 12th, 1999 • Chiron Corp • Pharmaceutical preparations • Delaware
EXHIBIT 10.78 [CONFIDENTIAL TREATMENT REQUESTED] [Certain information has been omitted herein pursuant to a request for confidential treatment pursuant to Rule 24b-2.] INVESTMENT, RESEARCH SUPPORT AND MARKETING AGREEMENT This Agreement is made as of...Royalty Agreement • November 15th, 1995 • Chiron Corp • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.56 [CONFIDENTIAL TREATMENT REQUESTED] [Certain confidential information has been omitted from the Agreement and filed separately with the Securities and Exchange Commission pursuant to a request by Registrant for confidential treatment...License Agreement • November 12th, 1996 • Chiron Corp • Pharmaceutical preparations • California
EXHIBIT 10.202** CONFIDENTIAL TREATMENTLicense and Supply Agreement • May 13th, 1999 • Chiron Corp • Pharmaceutical preparations • New Jersey
RECITALS --------Revolving Credit Agreement • August 11th, 1997 • Chiron Corp • Pharmaceutical preparations • California
ARTICLE I DEFINITIONSGovernance Agreement • August 12th, 1999 • Chiron Corp • Pharmaceutical preparations • Delaware
offerings of securities of the Company owned by the Shareholder. NOW, THEREFORE, in consideration of the covenants and agreements contained herein, in the Investment Agreement and in the other Ancillary Agreements, and for other good and valuable...Registration Rights Agreement • August 12th, 1999 • Chiron Corp • Pharmaceutical preparations • Delaware
EXHIBIT 10.21 FIRST AMENDMENT --------------- FIRST AMENDMENT to CREDIT AGREEMENT (this "First Amendment") dated as of March 20, 1996 between CHIRON CORPORATION (the "Borrower"), and SWISS BANK CORPORATION, SAN FRANCISCO BRANCH (the "Bank")....Credit Agreement • May 14th, 1997 • Chiron Corp • Pharmaceutical preparations • California
BGR III Lease] SECOND AMENDMENT TO TRIPLE NET LEASE THIS SECOND AMENDMENT TO TRIPLE NET LEASE (this "Second Amendment") is entered as of the 31st day of January, 1997, by and between BGR ASSOCIATES III, A CALIFORNIA LIMITED PARTNERSHIP ("Lessor"), and...Chiron Corp • March 31st, 1997 • Pharmaceutical preparations
betweenChiron Corp • March 28th, 1996 • In vitro & in vivo diagnostic substances • New York
RECITALSAsset Transfer Agreement • December 15th, 1998 • Chiron Corp • Pharmaceutical preparations • New York
CONFIDENTIAL TREATMENT REQUESTED** BLOOD SCREENING HCV/HIV PROBE LICENSE AGREEMENT BETWEENLicense and Option Agreement • November 7th, 2000 • Chiron Corp • Pharmaceutical preparations
LOGO] CONTRACT MANUFACTURING AGREEMENT THIS CONTRACT MANUFACTURING AGREEMENT (the "Agreement") is made and entered into as of March 17, 2000 ("Date of Agreement"), by and between: Chiron S.p.A., with its registered offices at Via Fiorentina 1, 53100...Contract Manufacturing Agreement • August 8th, 2000 • Chiron Corp • Pharmaceutical preparations
CONFIDENTIAL TREATMENT REQUESTED*** STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 10th, 1998 • Chiron Corp • Pharmaceutical preparations • New York
EXHIBIT 10.203 CONFIDENTIAL TREATMENT REGULATORY FILING, DEVELOPMENT AND SUPPLY AGREEMENTAgreement • March 16th, 1999 • Chiron Corp • Pharmaceutical preparations • California
Exhibit 10.103 GUARANTY CETUS REGARDING CHIRON NOTES THIS GUARANTY (this "Guaranty"), dated as of September 29, 1994, is made by Cetus Corporation, a Delaware corporation (the "Guarantor"), in favor of The First National Bank of Boston, as trustee...Chiron Corp • August 12th, 1999 • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 9th, 2004 • Chiron Corp • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT is made and entered into as of June 22, 2004 by and between Chiron Corporation, a Delaware corporation (the "Company"), and Credit Suisse First Boston LLC and Morgan Stanley & Co. Incorporated (collectively, the "Initial Purchasers"), pursuant to a purchase agreement, dated June 16, 2004 (the "Purchase Agreement"), between the Company and the Initial Purchasers. In order to induce the Initial Purchasers to enter into the Purchase Agreement, the Company has agreed to provide the registration rights set forth in this Agreement. The execution of this Agreement is a condition to the closing under the Purchase Agreement.
ARTICLE II Representations and Warranties of ChironStock Purchase Agreement • January 13th, 1998 • Chiron Corp • Pharmaceutical preparations • California
COMMERCIAL LEASEChiron Corp • March 28th, 1996 • In vitro & in vivo diagnostic substances
